Literature DB >> 32803171

Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment.

Pierre Bost1,2,3, Idan Milo4, Ronan Thibaut4,5, Marine Cazaux4,5, Fabrice Lemaître4, Zacarias Garcia4, Ido Amit1, Béatrice Breart4, Clémence Cornuot4, Benno Schwikowski2, Philippe Bousso6.   

Abstract

The cytokine IFN-γ produced by tumor-reactive T cells is a key effector molecule with pleiotropic effects during anti-tumor immune responses. While IFN-γ production is targeted at the immunological synapse, its spatiotemporal activity within the tumor remains elusive. Here, we report that while IFN-γ secretion requires local antigen recognition, IFN-γ diffuses extensively to alter the tumor microenvironment in distant areas. Using intravital imaging and a reporter for STAT1 translocation, we provide evidence that T cells mediate sustained IFN-γ signaling in remote tumor cells. Furthermore, tumor phenotypic alterations required several hours of exposure to IFN-γ, a feature that disfavored local IFN-γ activity over diffusion and bystander activity. Finally, single-cell RNA-seq data from melanoma patients also suggested bystander IFN-γ activity in human tumors. Thus, tumor-reactive T cells act collectively to create large cytokine fields that profoundly modify the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32803171      PMCID: PMC7115926          DOI: 10.1038/s43018-020-0038-2

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


  43 in total

Review 1.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

2.  Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.

Authors:  Thomas Kammertoens; Christian Friese; Ainhoa Arina; Christian Idel; Dana Briesemeister; Michael Rothe; Andranik Ivanov; Anna Szymborska; Giannino Patone; Severine Kunz; Daniel Sommermeyer; Boris Engels; Matthias Leisegang; Ana Textor; Hans Joerg Fehling; Marcus Fruttiger; Michael Lohoff; Andreas Herrmann; Hua Yu; Ralph Weichselbaum; Wolfgang Uckert; Norbert Hübner; Holger Gerhardt; Dieter Beule; Hans Schreiber; Thomas Blankenstein
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962

Review 3.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

4.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

Authors:  S E Street; E Cretney; M J Smyth
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

5.  Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Authors:  Jianjun Gao; Lewis Zhichang Shi; Hao Zhao; Jianfeng Chen; Liangwen Xiong; Qiuming He; Tenghui Chen; Jason Roszik; Chantale Bernatchez; Scott E Woodman; Pei-Ling Chen; Patrick Hwu; James P Allison; Andrew Futreal; Jennifer A Wargo; Padmanee Sharma
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

6.  T-helper-1-cell cytokines drive cancer into senescence.

Authors:  Heidi Braumüller; Thomas Wieder; Ellen Brenner; Sonja Aßmann; Matthias Hahn; Mohammed Alkhaled; Karin Schilbach; Frank Essmann; Manfred Kneilling; Christoph Griessinger; Felicia Ranta; Susanne Ullrich; Ralph Mocikat; Kilian Braungart; Tarun Mehra; Birgit Fehrenbacher; Julia Berdel; Heike Niessner; Friedegund Meier; Maries van den Broek; Hans-Ulrich Häring; Rupert Handgretinger; Leticia Quintanilla-Martinez; Falko Fend; Marina Pesic; Jürgen Bauer; Lars Zender; Martin Schaller; Klaus Schulze-Osthoff; Martin Röcken
Journal:  Nature       Date:  2013-02-03       Impact factor: 49.962

7.  Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.

Authors:  D H Kaplan; V Shankaran; A S Dighe; E Stockert; M Aguet; L J Old; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

9.  Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Authors:  Christopher S Garris; Sean P Arlauckas; Rainer H Kohler; Marcel P Trefny; Seth Garren; Cécile Piot; Camilla Engblom; Christina Pfirschke; Marie Siwicki; Jeremy Gungabeesoon; Gordon J Freeman; Sarah E Warren; SuFey Ong; Erica Browning; Christopher G Twitty; Robert H Pierce; Mai H Le; Alain P Algazi; Adil I Daud; Sara I Pai; Alfred Zippelius; Ralph Weissleder; Mikael J Pittet
Journal:  Immunity       Date:  2018-12-11       Impact factor: 43.474

10.  CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy.

Authors:  Weimin Wang; Michael Green; Jae Eun Choi; Miguel Gijón; Paul D Kennedy; Jeffrey K Johnson; Peng Liao; Xueting Lang; Ilona Kryczek; Amanda Sell; Houjun Xia; Jiajia Zhou; Gaopeng Li; Jing Li; Wei Li; Shuang Wei; Linda Vatan; Hongjuan Zhang; Wojciech Szeliga; Wei Gu; Rebecca Liu; Theodore S Lawrence; Candice Lamb; Yuri Tanno; Marcin Cieslik; Everett Stone; George Georgiou; Timothy A Chan; Arul Chinnaiyan; Weiping Zou
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

View more
  38 in total

1.  IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells.

Authors:  Can Fang; Tao Weng; Shaojie Hu; Zhiwei Yuan; Hui Xiong; Bing Huang; Yixin Cai; Lequn Li; Xiangning Fu
Journal:  Oncoimmunology       Date:  2021-08-10       Impact factor: 8.110

2.  Characterizing Macrophage Diversity in Metastasis-Bearing Lungs Reveals a Lipid-Associated Macrophage Subset.

Authors:  Danielle N Huggins; Rebecca S LaRue; Ying Wang; Todd P Knutson; Yingzheng Xu; Jesse W Williams; Kathryn L Schwertfeger
Journal:  Cancer Res       Date:  2021-08-13       Impact factor: 12.701

Review 3.  Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

Authors:  Mirjam E Hoekstra; Saskia V Vijver; Ton N Schumacher
Journal:  Curr Opin Immunol       Date:  2021-04-13       Impact factor: 7.486

4.  A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Authors:  Ranjan Upadhyay; Jonathan A Boiarsky; Gvantsa Pantsulaia; Judit Svensson-Arvelund; Matthew J Lin; Aleksandra Wroblewska; Sherry Bhalla; Nathalie Scholler; Adrian Bot; John M Rossi; Norah Sadek; Samir Parekh; Alessandro Lagana; Alessia Baccarini; Miriam Merad; Brian D Brown; Joshua D Brody
Journal:  Cancer Discov       Date:  2020-12-17       Impact factor: 39.397

5.  CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.

Authors:  Lauren Giuffrida; Kevin Sek; Melissa A Henderson; Junyun Lai; Amanda X Y Chen; Deborah Meyran; Kirsten L Todd; Emma V Petley; Sherly Mardiana; Christina Mølck; Gregory D Stewart; Benjamin J Solomon; Ian A Parish; Paul J Neeson; Simon J Harrison; Lev M Kats; Imran G House; Phillip K Darcy; Paul A Beavis
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

6.  Quorum sensing governs collective dendritic cell activation in vivo.

Authors:  Margot Bardou; Jérémy Postat; Clémence Loaec; Fabrice Lemaître; Gustave Ronteix; Zacarias Garcia; Philippe Bousso
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

7.  cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Authors:  Kevin Roehle; Li Qiang; Katherine S Ventre; Daniel Heid; Lestat R Ali; Patrick Lenehan; Max Heckler; Stephanie J Crowley; Courtney T Stump; Gabrielle Ro; Anže Godicelj; Aladdin M Bhuiyan; Annan Yang; Maria Quiles Del Rey; Tamara Biary; Adrienne M Luoma; Patrick T Bruck; Jana F Tegethoff; Svenja L Nopper; Jinyang Li; Katelyn T Byrne; Marc Pelletier; Kai W Wucherpfennig; Ben Z Stanger; James J Akin; Joseph D Mancias; Judith Agudo; Michael Dougan; Stephanie K Dougan
Journal:  Sci Transl Med       Date:  2021-05-19       Impact factor: 19.319

Review 8.  MLKL in cancer: more than a necroptosis regulator.

Authors:  Peter Vandenabeele; Nozomi Takahashi; Sofie Martens; Jolien Bridelance; Ria Roelandt
Journal:  Cell Death Differ       Date:  2021-05-05       Impact factor: 12.067

Review 9.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

Review 10.  Understanding breast cancer heterogeneity through non-genetic heterogeneity.

Authors:  Neda Barzgar Barough; Fakhrosadat Sajjadian; Nazila Jalilzadeh; Hajar Shafaei; Kobra Velaei
Journal:  Breast Cancer       Date:  2021-03-15       Impact factor: 4.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.